Is Crigler-Najjar syndrome hereditary?

Crigler-Najjar syndrome is an inherited, autosomal recessive genetic disorder caused by mutations in the UGT1A1 gene, meaning it is passed down through families rather than occurring spontaneously. Because it follows an autosomal recessive inheritance pattern, an individual must inherit two copies of the mutated gene—one from each carrier parent—to manifest the condition.

Is Crigler-Najjar syndrome strictly hereditary?

Yes, Crigler-Najjar syndrome is a hereditary condition, meaning it is caused by genetic changes that are inherited from parents. It is important to distinguish between "genetic" (caused by a mutation in DNA) and "hereditary" (passed from parents to offspring). While all cases of Crigler-Najjar syndrome are genetic in origin, they are specifically hereditary, as the condition results from biallelic mutations in the UGT1A1 gene. De novo (spontaneous) mutations are extremely rare in this syndrome; nearly all affected individuals have inherited one mutated allele from each parent.

What is the inheritance pattern of Crigler-Najjar syndrome?

Crigler-Najjar syndrome is inherited in an autosomal recessive pattern. This means that both parents of an affected child are typically asymptomatic carriers of a single mutated UGT1A1 gene copy. When both parents are carriers, the risks for each pregnancy are as follows:

• 25% chance the child will inherit two mutated copies and have Crigler-Najjar syndrome.


• 50% chance the child will inherit one mutated copy and be an asymptomatic carrier.


• 25% chance the child will inherit two normal copies and neither have the syndrome nor be a carrier.

How is genetic testing used for diagnosis and family planning?

Genetic testing for Crigler-Najjar syndrome is the gold standard for confirming a clinical diagnosis and identifying the specific UGT1A1 mutation. Testing involves sequencing the gene to identify the pathogenic variants. It is highly recommended for families who have a history of the condition, particularly when planning pregnancies. Genetic counseling plays a vital role in helping families understand these inheritance risks. Counselors can provide clarity on the probability of recurrence and discuss options such as carrier testing for family members or prenatal diagnostic testing (such as chorionic villus sampling or amniocentesis) for those who wish to know the status of a fetus during pregnancy.

Why is genetic counseling important for families?

For the 35 individuals with Crigler-Najjar syndrome currently connected through the DiseaseMaps.org community, genetic counseling provides a space to address the emotional and logistical realities of a rare disease diagnosis. Beyond calculating recurrence risks, genetic counselors help families navigate the implications of being a carrier and assist in communicating this information to extended family members who may also be at risk of being carriers. Understanding the genetic nature of Crigler-Najjar syndrome empowers parents to make informed medical decisions and ensures that all family members receive appropriate screening and support.

Next steps

• Consult a clinical geneticist to verify the specific UGT1A1 mutation present in your family.


• Request a referral to a genetic counselor to discuss family planning and carrier testing for relatives.


• Connect with the Crigler-Najjar syndrome community at DiseaseMaps.org to share experiences and access peer-driven support.


• Maintain regular follow-ups with a pediatric hepatologist or metabolic specialist to manage bilirubin levels.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Crigler-Najjar syndrome overview.


• Orphanet: Rare disease database entry for Crigler-Najjar syndrome.


• OMIM (Online Mendelian Inheritance in Man): UGT1A1 gene and Crigler-Najjar syndrome entries.


• PubMed: Clinical reviews on the molecular genetics of UGT1A1-related disorders.